Righto. So I just spent nearly 45 minutes reading through the 10Q and am now exhausted .
One part stuck out to me regarding the exclusivity letter signed between UNIS and AMGEN. This is the clause
"(x) the purchase of any capital stock or other equity interest in, or any of the businesses of, Unilife or any of its Subsidiaries, (y) any merger, share exchange, tender offer, business combination, consolidation, joint venture, restructuring, reorganization, recapitalization, spin-off, split-off or other alternative transaction involving any capital stock, businesses or assets of Unilife or any of its Subsidiaries, or (z) any direct or indirect sale, license, lease, transfer, pledge, exchange or other disposition of any material portion of the assets or liabilities of Unilife or any of its Subsidiaries, including any amendment to an existing agreement to do any of the foregoing and including any exclusive license involving any Unilife delivery devices, delivery platforms or the intellectual property related thereto; and (iv) the term “Subsidiary” means, as to any Person, any other Person of which such Person directly or indirectly (through one or more subsidiaries) owns or controls (x) at least a majority of the outstanding equity or economic interests or (y) securities or ownership interests having by their terms ordinary voting power to elect at least a majority of the board of directors or other Persons performing similar functions. "
I could be wrong but to me this
"including any amendment to an existing agreement to do any of the foregoing and including any exclusive license involving any Unilife delivery devices, delivery platforms or the intellectual property related thereto"
Means that UNIS is unable to amend any current agreement with a potential customer which could be another reason that Abbvie is delayed. We know that agreement has expanded beyond the original deal so maybe Amgen is going to lock them out of any amendment until they are finished with UNIS.
Just got me thinking about AMGENS intentions with us. Very interesting to me. This exclusivity agreement they've signed is water tight. Just confirmed to me that a deal is happening.
Anyway. All IMO.
Goodluck guys.
UNS Price at posting:
24.0¢ Sentiment: Buy Disclosure: Held